BriefCase-Triage

The BriefCase-Triage device is a radiological computer-assisted triage software designed to rapidly identify potential cervical spine fractures in adult CT scans by flagging linear lucencies, leveraging AI to improve workflow prioritization. It operates as a notification tool, not a diagnostic one, demonstrating high sensitivity (92.1%) and specificity (92.6%) in retrospective studies, while significantly reducing time-to-notification for suspected cases to 15.1 seconds.

The BriefCase-Triage device, developed by Aidoc Medical, Ltd., is a radiological computer-assisted triage and notification software for analyzing adult cervical spine CT scans. Its primary function is to identify and flag linear lucencies indicative of potential fractures, providing rapid notifications and low-quality preview images to aid hospital networks and medical specialists in workflow prioritization. Crucially, the device is not intended for primary diagnosis and does not alter the original medical images. Performance data from a retrospective study showed the software's effectiveness, achieving a sensitivity of 92.1% and a specificity of 92.6% in detecting cervical spine fractures. The BriefCase-Triage device also demonstrated a significant reduction in time-to-notification for suspected cases, averaging 15.1 seconds, which represents a substantial improvement in preemptive triage efficiency compared to a predicate device. This enhanced speed directly contributes to clinicians' ability to prioritize critical cases and improve overall workflow.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific types of cervical spine fractures (e.g., stable vs. unstable, simple vs. comminuted) does the BriefCase-Triage device perform best in identifying?; How does the device account for imaging artifacts or anatomical variants that might present as linear lucencies, and what is the associated false positive rate?; Beyond time-to-notification, what are the observed impacts of BriefCase-Triage on overall patient management, treatment initiation, and clinical outcomes?; What are the implications for clinical responsibility and liability when using an AI-assisted triage tool that is not intended for primary diagnosis?; Has the BriefCase-Triage device demonstrated consistent performance across different CT scanner models, imaging protocols, and diverse patient demographics?